Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies (Q81310348)
Jump to navigation
Jump to search
scientific article published on 01 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies |
scientific article published on 01 September 2007 |
Statements
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies (English)
Shivaani Kummar
Martin Gutierrez
Erin R Gardner
Erin Donovan
Kyunghwa Hwang
Eun Joo Chung
Min-Jung Lee
Kim Maynard
Mikhail Kalnitskiy
Alice Chen
Giovanni Melillo
Qin C Ryan
Barbara Conley
William D Figg
James Zwiebel
James H Doroshow